US Patent 11591332 IRAK degraders and uses thereof
Patent 11591332 was granted and assigned to Kymera Therapeutics on February, 2023 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
December 17, 2020
Date of Patent
February 28, 2023
Patent Applicant
Patent Application Number
17125934
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11591332 IRAK degraders and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
